SEC Form 4 · accession 0001209191-17-031159
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven B Ruchefsky
Director
Period of report
May 9, 2017
Accepted (ET)
May 10, 2017 · 12:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 9, 2017 | P | 1,400 | $69.50 | A | 225,426 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 136,038 shares, previously registered in the name of Commercial Street Capital, LLC, which were distributed to the Reporting Person on April 3, 2017 in a pro rata distribution and are now owned directly.